Quadrature Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,973
| Closed | -$646K | – | 1537 |
|
|
2024
Q4 | $646K | Buy |
+1,973
| New | +$646K | 0.01% | 522 |
|
|
2023
Q1 | – | Sell |
-37,382
| Closed | -$8.8M | – | 1208 |
|
|
2022
Q4 | $8.8M | Buy |
+37,382
| New | +$8.8M | 0.26% | 93 |
|
|
2021
Q2 | – | Sell |
-1,300
| Closed | -$366K | – | 1262 |
|
|
2021
Q1 | $366K | Buy |
+1,300
| New | +$366K | 0.02% | 565 |
|
|
2020
Q4 | – | Sell |
-1,400
| Closed | -$385K | – | 1094 |
|
|
2020
Q3 | $385K | Buy |
+1,400
| New | +$385K | 0.02% | 532 |
|
|
2020
Q2 | – | Sell |
-6,288
| Closed | -$959K | – | 834 |
|
|
2020
Q1 | $959K | Buy |
6,288
+592
| +10% | +$90.3K | 0.23% | 128 |
|
|
2019
Q4 | $856K | Buy |
+5,696
| New | +$856K | 0.03% | 295 |
|
|
2019
Q3 | – | Sell |
-5,960
| Closed | -$745K | – | 688 |
|
|
2019
Q2 | $745K | Buy |
+5,960
| New | +$745K | 0.05% | 263 |
|
|
2017
Q3 | – | Sell |
-19,417
| Closed | -$1.84M | – | 679 |
|
|
2017
Q2 | $1.84M | Buy |
+19,417
| New | +$1.84M | 0.14% | 165 |
|